News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

XDx, Inc. Announces Presentations at Upcoming 2013 International Society for Heart and Lung Transplantation Meeting


4/24/2013 9:55:14 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

XDx, Inc., a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value non-invasive tests to monitor immune status in transplant recipients and autoimmune diseases, today announced clinical investigators will present results from six AlloMapĀ® studies at the 33rd Annual Meeting and Scientific Sessions of the International Society of Heart and Lung Transplantation (ISHLT), taking place April 24-27, 2013 at the Palais des Congres in Montreal, Canada.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
XDx, Inc.
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES